Patron Partners LLC purchased a new position in shares of Danaher Corporation (NYSE:DHR – Free Report) during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 2,413 shares of the conglomerate’s stock, valued at approximately $460,000.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in DHR. Main Street Group LTD bought a new position in shares of Danaher in the first quarter worth about $25,000. N.E.W. Advisory Services LLC bought a new stake in shares of Danaher during the second quarter valued at approximately $25,000. JPL Wealth Management LLC bought a new stake in shares of Danaher during the third quarter valued at approximately $25,000. WFA of San Diego LLC acquired a new stake in shares of Danaher in the second quarter valued at approximately $26,000. Finally, Hilton Head Capital Partners LLC bought a new position in Danaher in the 4th quarter worth approximately $27,000. Institutional investors and hedge funds own 79.05% of the company’s stock.
Danaher Trading Up 1.6%
Shares of NYSE DHR opened at $219.42 on Friday. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80. The firm has a market capitalization of $154.25 billion, a P/E ratio of 38.97, a P/E/G ratio of 2.69 and a beta of 0.78. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. The company’s 50 day simple moving average is $195.80 and its 200 day simple moving average is $192.61.
Wall Street Analyst Weigh In
Several research analysts have issued reports on the company. Royal Bank Of Canada upped their price objective on Danaher from $200.00 to $215.00 and gave the stock an “outperform” rating in a report on Wednesday, July 22nd. Wall Street Zen cut Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, April 25th. Wolfe Research downgraded Danaher from an “outperform” rating to a “peer perform” rating in a research report on Monday, June 1st. Guggenheim cut their price target on Danaher from $235.00 to $200.00 and set a “buy” rating on the stock in a research note on Wednesday, July 22nd. Finally, Piper Sandler initiated coverage on Danaher in a report on Thursday, June 11th. They issued a “neutral” rating and a $200.00 price target on the stock. One investment analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $228.91.
Check Out Our Latest Analysis on Danaher
Danaher Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Featured Stories
- Five stocks we like better than Danaher
- Blueprint for a Boom: SEC Clears the Crypto Runway
- Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss
- Advance Auto Parts Plunged, But Its Turnaround Is Still Working
- Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates?
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
